| 1 |
9143391 | Phase I trial of subcutaneous interleukin-1 alpha in children with malignant solid tumors. | 1997 Jun |
2 |
| 2 |
9298933 | Interleukin-1alpha synergistic in vivo enhancement of cyclophosphamide- and carboplatin-mediated antitumor activity. | 1997 Aug |
3 |
| 3 |
8911126 | Effects of interleukin-1 alpha on ovarian carcinoma in patients with recurrent disease. | 1996 Aug |
2 |
| 4 |
8912565 | A characteristic eruption associated with ifosfamide, carboplatin, and etoposide chemotherapy after pretreatment with recombinant interleukin-1 alpha. | 1996 Nov |
1 |
| 5 |
8938138 | Sensitization by interleukin-1alpha of carboplatinum anti-tumor activity against human ovarian (NIH:OVCAR-3) carcinoma cells in vitro and in vivo. | 1996 Nov 27 |
10 |
| 6 |
7847805 | Potentiation of antitumor activities of carboplatin and camptothecin by interleukin-1 alpha against human ovarian carcinoma in vivo. | 1994 Sep-Oct |
2 |
| 7 |
8151314 | Effects of interleukin-1 alpha on carboplatin-induced thrombocytopenia in patients with recurrent ovarian cancer. | 1994 Apr |
7 |
| 8 |
8437596 | The effects of treatment with interleukin-1 alpha on platelet recovery after high-dose carboplatin. | 1993 Mar 18 |
5 |
| 9 |
1638519 | Prevention of acute chemotherapy-induced death in mice by recombinant human interleukin 1: protection from hematological and nonhematological toxicities. | 1992 Aug 1 |
1 |